Cargando…

Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy

Promoting the degradation of Hsp90 client proteins by inhibiting Hsp90, an important protein chaperone, has been shown to be a promising new anticancer strategy. In this study, we show that an oxazoline analogue of apratoxin A (oz-apraA), a cyclodepsipeptide isolated from a marine cyanobacterium, pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Shensi, Zhang, Pengtao, Lovchik, Martin A., Li, Ying, Tang, Liuya, Chen, Zhimin, Zeng, Rong, Ma, Dawei, Yuan, Junying, Yu, Qiang
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2009
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711573/ https://www.ncbi.nlm.nih.gov/pubmed/19433452 http://dx.doi.org/10.1083/jcb.200810183

Ejemplares similares

Hsp110 Chaperones Control Client Fate Determination in the Hsp70–Hsp90 Chaperone System
por: Mandal, Atin K., et al.
Publicado: (2010)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

A switch point in the molecular chaperone Hsp90 responding to client interaction
por: Rutz, Daniel Andreas, et al.
Publicado: (2018)

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins
por: Smith, Jennifer R., et al.
Publicado: (2013)

Hsp90 Chaperones Bluetongue Virus Proteins and Prevents Proteasomal Degradation
por: Mohl, Bjorn-Patrick, et al.
Publicado: (2019)

Structural elements in the flexible tail of the co-chaperone p23 coordinate client binding and progression of the Hsp90 chaperone cycle
por: Biebl, Maximilian M., et al.
Publicado: (2021)

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
por: Lackie, Rachel E., et al.
Publicado: (2017)

The disruption of protein−protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition
por: Serwetnyk, Michael A., et al.
Publicado: (2021)

HECTD3 Mediates an HSP90-Dependent Degradation Pathway for Protein Kinase Clients
por: Li, Zhaobo, et al.
Publicado: (2017)

The chaperone system in cancer therapies: Hsp90
por: Basset, Charbel A., et al.
Publicado: (2023)

Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer
por: Ruckova, Eva, et al.
Publicado: (2012)

The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90
por: Alberti, Giusi, et al.
Publicado: (2022)

Hsp40s Specify Functions of Hsp104 and Hsp90 Protein Chaperone Machines
por: Reidy, Michael, et al.
Publicado: (2014)

SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90
por: Lian, Bin, et al.
Publicado: (2021)

Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies
por: Shelton, Lindsey B., et al.
Publicado: (2017)

Review: The HSP90 molecular chaperone—an enigmatic ATPase
por: Pearl, Laurence H.
Publicado: (2016)

Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases
por: Bohush, Anastasiia, et al.
Publicado: (2019)

Hsp90 and Associated Co-Chaperones of the Malaria Parasite
por: Dutta, Tanima, et al.
Publicado: (2022)

The regulatory mechanism of a client kinase controlling its own release from Hsp90 chaperone machinery through phosphorylation
por: Lu, Xin-an, et al.
Publicado: (2013)

Tumor suppressor Tsc1 is a new Hsp90 co‐chaperone that facilitates folding of kinase and non‐kinase clients
por: Woodford, Mark R, et al.
Publicado: (2017)

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation
por: Bhattacharya, Kaushik, et al.
Publicado: (2020)

Distinct Roles of Molecular Chaperones HSP90α and HSP90β in the Biogenesis of KCNQ4 Channels
por: Gao, Yanhong, et al.
Publicado: (2013)

The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding
por: Woodford, Mark R., et al.
Publicado: (2016)

Insect chaperones Hsp70 and Hsp90 cooperatively enhance toxicity of Bacillus thuringiensis Cry1A toxins and counteract insect resistance
por: García-Gomez, Blanca Ines, et al.
Publicado: (2023)

Metabolic and Chaperone Gene Loss Marks the Origin of Animals: Evidence for Hsp104 and Hsp78 Chaperones Sharing Mitochondrial Enzymes as Clients
por: Erives, Albert J., et al.
Publicado: (2015)

The Structure of the R2TP Complex Defines a Platform for Recruiting Diverse Client Proteins to the HSP90 Molecular Chaperone System
por: Rivera-Calzada, Angel, et al.
Publicado: (2017)

HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis
por: Albakova, Zarema, et al.
Publicado: (2022)

Folding or holding?—Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease
por: Rutledge, Benjamin S., et al.
Publicado: (2022)

Tamoxifen Enhances the Hsp90 Molecular Chaperone ATPase Activity
por: Zhao, Rongmin, et al.
Publicado: (2010)

Molecular Chaperone Hsp90 Is a Therapeutic Target for Noroviruses
por: Vashist, Surender, et al.
Publicado: (2015)

Extended conformational states dominate the Hsp90 chaperone dynamics
por: Jussupow, Alexander, et al.
Publicado: (2022)

Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains
por: Czemeres, Josh, et al.
Publicado: (2017)

Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation
por: Zhang, Y, et al.
Publicado: (2014)

Activation of autophagy depends on Atg1/Ulk1-mediated phosphorylation and inhibition of the Hsp90 chaperone machinery
por: Backe, Sarah J., et al.
Publicado: (2023)

Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo
por: Tillotson, Bonnie, et al.
Publicado: (2010)

Corrigendum: HSP70 and HSP90 in cancer: cytosolic, endoplasmic reticulum and mitochondrial chaperones of tumorigenesis
por: Albakova, Zarema, et al.
Publicado: (2023)

Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
por: Gillis, Joanna L., et al.
Publicado: (2013)

COMPARTMENTALIZED CANCER DRUG DISCOVERY TARGETING MITOCHONDRIAL Hsp90 CHAPERONES
por: Kang, Byoung Heon, et al.
Publicado: (2009)

Natural Iminosugar (+)-Lentiginosine Inhibits ATPase and Chaperone Activity of Hsp90
por: Dal Piaz, Fabrizio, et al.
Publicado: (2012)

Cooperation of local motions in the Hsp90 molecular chaperone ATPase mechanism
por: Schulze, Andrea, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rirgne6mvo9l99nmeb8ks83ial